Skip to main content
. Author manuscript; available in PMC: 2013 Aug 1.
Published in final edited form as: Cell Tissue Res. 2012 Apr 18;349(2):541–550. doi: 10.1007/s00441-012-1415-7

Fig. 6.

Fig. 6

The effect of a 24 h exposure of saracatinib (1–10 μM) on HMVEC-L Src and Src phosphorylation (a), tube formation (b–e), and motility (f) are illustrated. Bars in b–e equal 100 μ. The level of VEGF determined in the media of KHT sarcoma cells after a 24 h saracatinib treatment is shown in (g). Data are the results from three independent experiments ± SE; stars = P<0.05 versus control.